Changchun Genescience Pharmaceutical Co., Ltd.
Clinical trials sponsored by Changchun Genescience Pharmaceutical Co., Ltd., explained in plain language.
-
New combo therapy shows promise for tough stomach cancer
Disease control CompletedThis study tested a new drug called gentuximab combined with the chemotherapy paclitaxel in 76 people with advanced stomach or gastroesophageal junction cancer that had worsened after initial treatment. The goal was to find safe doses and see if the combination could shrink tumor…
Phase: PHASE1, PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Disease control
Last updated Jun 15, 2026 19:02 UTC
-
New pill aims to cool menopausal hot flashes
Symptom relief CompletedThis study tested a new tablet called GS1-144 to see if it can safely reduce moderate to severe hot flashes in Chinese women going through menopause. 129 women took either the study drug or a placebo for up to 12 weeks. The main goal was to see if the drug lowered the number and …
Phase: PHASE2 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Symptom relief
Last updated Jun 08, 2026 13:18 UTC
-
New autoimmune drug candidate takes first step in human trials
Knowledge-focused CompletedThis early-stage study tested a single injection of a new drug called GenSci120 in 58 healthy adults in China. The main goal was to check if the drug is safe and how the body processes it. This is a first step before testing the drug in people with autoimmune diseases.
Phase: PHASE1 • Sponsor: Changchun GeneScience Pharmaceutical Co., Ltd. • Aim: Knowledge-focused
Last updated Jun 05, 2026 12:07 UTC